BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang T, Hui R, Nouws J, Sauler M, Zeng T, Wu Q. Untargeted metabolomics analysis of esophageal squamous cell cancer progression. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03311-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang X, Wang P, Ye H, Jiang M, Su Y, Peng X, Li H, Zhang J. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer. Front Oncol 2022;12:938234. [DOI: 10.3389/fonc.2022.938234] [Reference Citation Analysis]
2 Yan C, Wu D, Gan L, Wang J, Yang W, Xu B. Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy. Front Pharmacol 2022;13:949745. [DOI: 10.3389/fphar.2022.949745] [Reference Citation Analysis]
3 Guo K, Li K. Screening of four key genes in esophageal carcinoma based on TCGA and GEO data and verification of anti-proliferative effect of LAPTM4B knockdown in esophageal carcinoma cells invitro. Arch Biochem Biophys 2022;728:109352. [PMID: 35863479 DOI: 10.1016/j.abb.2022.109352] [Reference Citation Analysis]
4 Jiang W, Wang X, Su S, Du S, Song H. Identifying the shared genes and KEGG pathways of Resolvin D1-targeted network and osteoarthritis using bioinformatics. Bioengineered 2022;13:9839-54. [PMID: 35436417 DOI: 10.1080/21655979.2022.2061288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]